Runtao Li

Title: Innovator Spotlight: Runtao Li from Beijing

Introduction: Runtao Li is a distinguished inventor based in Beijing, China, with a focus on advanced pharmaceutical compounds and methods. With a total of four patents to his name, Li has made significant contributions to the fields of medicine and pharmacology, particularly concerning pain management and therapeutic compounds.

Latest Patents: Among his latest inventions is an innovative anti-pain compound and its preparation method. This patent discloses a compound represented by a specific formula, which can be utilized in the manufacture of medications aimed at treating neuropathic pain and associated syndromes, as well as combating inflammation. Another noteworthy invention by Li is a urea peptoid boric acid compound, accompanied by pharmaceutical compositions, preparative methods, and various uses. This urea peptidomimetic boronic compound is also represented by a designated formula, showcasing his dedication to creating effective pharmaceutical solutions.

Career Highlights: Runtao Li has been associated with esteemed institutions such as Peking University, contributing to research and development in pharmaceutical sciences. He has also worked at Zhengzhou Granlen Pharmatech Ltd., where he leveraged his expertise to advance medical innovations.

Collaborations: Throughout his career, Li has collaborated with notable professionals in the field, including coworkers Zemei Ge and Tieming Cheng. These collaborations have further enhanced the potential applications and success of his inventions.

Conclusion: With a strong portfolio of patents and impactful collaborations, Runtao Li continues to push the boundaries of innovation in the pharmaceutical industry. His focus on developing compounds that address critical health issues marks him as a prominent figure in contemporary medical research and development.